Celsion Corporation’s stock rises by 36.63% within a day. Since May 19 CLSN could grow from $1.47 to $2.35. Last Friday its Q1 2020 report was released thus triggering significant growth in stock price. Despite the net loss per common share of $0.20, the total asset increased by $659.000 and total liabilities decreased from $23.719.000 to $22.728.000.
The most interesting is the total volume exceeds the average volume by almost 2100% which occurred on May 20. Oncology based companies usually do not achieve positive net income as they spent a lot of funds to create new medicine and technology to fight the diseases in that particular field. Investors normally do not pay attention to their net losses rather they observe companies’ success in research and development projects.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life